As we near the completion of the second year of REPRESSIT, all members of the consortium gathered in Oxford on 10th-11th February 2025. The meeting was hosted by the Fernandes Lab at the University of Oxford. Participants from all five project partners -Oxford, AMOLF, UKB, UMCU and KI- discussed the progress made so far, ongoing…
First year of REPRESSIT
In the complex world of cancer, immune cells called T cells are a critical part of our bodies’ arsenal to combat tumor cells. They play a crucial role in “finishing the job” when patients are treated for cancer with chemotherapy or radiation. Unfortunately, in some patients, these cells are often ‘shut down’ by inhibitory immune…